ArticleClinical and experimental nephrology2026
Associations between cardiovascular health metrics and mortality among adults with chronic kidney disease.
Article in Clinical and experimental nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to evaluate the associations between cardiovascular health (CVH) scores, measured by Life's Simple 7 (LS7), Life's Essential 8 (LE8), and Life's Crucial 9 (LC9), and the risks of all-cause and cardio-cerebrovascular disease (CCD) mortality among individuals with chronic kidney disease (CKD).
methodsData from 4,989 adults with CKD in the National Health and Nutrition Examination Survey (NHANES) 2005-2018 were analyzed. Cox proportional hazards regression models assessed associations between CVH metrics and mortality risks. Predictive performance was evaluated using receiver operating characteristic (ROC) curves and area under the curve (AUC) values at 3-, 5-, and 10 year follow-ups.
resultsDuring a median follow-up of 6.2 years, higher CVH scores across all metrics were associated with significantly lower risks of all-cause and CCD mortality. Higher CVH scores were significantly associated with lower risks of all-cause and CCD mortality. For all-cause mortality, participants with the highest LS7 scores (≥ 11) had a 71% lower risk (HR = 0.29, 95% CI: 0.18-0.46) compared to those with the lowest scores (≤ 4). Similarly, participants with the highest LE8 (> 79.9) and LC9 (> 79.9) scores had a 69% and 73% lower risk of all-cause mortality, respectively.
conclusionsLS7, LE8, and LC9 showed similar discrimination for all-cause and CCD mortality. Adding sleep and psychological health components did not meaningfully improve risk discrimination beyond LS7 in adults with CKD, supporting LS7 as a practical tool for mortality risk stratification.
Indexed as
Identifiers
41670754What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.